Amalgamated Bank
ASND icon

Amalgamated Bank’s Ascendis Pharma A/S ASND Stock Holding History

Amalgamated Bank’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$865K Buy
3,798
+179
+5% +$45.3K 0.01% 1124
2026
Q2 		$965K Buy
+3,619
New +$845K 0.01% 1125

Other funds holding ASND

Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Henry James International Management
Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Amalgamated Bank's ASND Position: Q3 2026 in Review

Amalgamated Bank increased its Ascendis Pharma A/S (ASND) stake by 4.9% in Q3 2026, buying an estimated $45.3K and bringing the position to 3,798 shares worth $865K. The position accounts for 0.01% of the portfolio, ranked #1124.

Amalgamated Bank first reported a position in ASND in Q2 2026 and has held it in 2 quarters since. The position peaked at $965K in Q2 2026. 43 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Amalgamated Bank held 3,798 shares of Ascendis Pharma A/S worth $865K as of Q3 2026.
  • Amalgamated Bank bought 179 Ascendis Pharma A/S shares in Q3 2026, an estimated $45.3K.
  • Ascendis Pharma A/S made up 0.01% of Amalgamated Bank's portfolio in Q3 2026, its #1124 holding.
  • Amalgamated Bank first reported a position in Ascendis Pharma A/S in Q2 2026 and has held it in 2 quarters since.
  • Amalgamated Bank's Ascendis Pharma A/S position peaked at $965K in Q2 2026.
  • 43 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Amalgamated Bank's 13F filing for Q3 2026, filed 23 Oct 2026.